|
| Exchange Disseminated Time | Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended September 30, 2014:
The Unaudited Standalone results for the Quarter ended September 30, 2014
The Company has posted a net profit of Rs. 1164.27 million for the quarter ended September 30, 2014 as compared to Rs. 1059.48 million for the quarter ended September 30, 2013. Total Income has increased from Rs. 6060.26 million for the quarter ended September 30, 2013 to Rs. 7117.53 million for the quarter ended September 30, 2014.
The Consolidated Results are as follows:
The Unaudited Consolidated results for the Quarter ended September 30, 2014
The Group has posted a net profit/(loss) after taxes, minority interest and share in profit/(loss) of associates of Rs. 1650.78 million for the quarter ended September 30, 2014 as compared to Rs. 1542.97 million for the quarter ended September 30, 2013. Total Income has increased from Rs. 14767.84 million for the quarter ended September 30, 2013 to Rs. 16816.78 million for the quarter ended September 30, 2014. |
|
|